Trial Profile
Intravenous vs. Intracoronary Use of Abciximab.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jan 2012
Price :
$35
*
At a glance
- Drugs Abciximab (Primary) ; Abciximab (Primary)
- Indications Coronary stent thrombosis; Myocardial infarction
- Focus Therapeutic Use
- 01 Dec 2011 Results published in Cardiology.
- 09 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2009 Results presented at the 82nd Annual Scientific Sessions of the American Heart Association.